Drawing for COMPLIDIOV

USPTO serial 78670236

COMPLIDIOV

Reviewed by CopyMark Law Group

Reg. 3214869Status 710
Filing date
Status date
Registration date
Mar 6, 2007
Examiner
MCROBBIE, JENNIFER
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with COMPLIDIOV?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, pharmaceutical preparations treating bacteria-based diseases, antivirals, anti-biotics, anti-fungalsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 11, 2013C8..CANCELLED SEC. 8 (6-YR)—
Jun 21, 2009TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 6, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 19, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 29, 2006NPUBNOTICE OF PUBLICATION—
Oct 31, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 27, 2006ALIEASSIGNED TO LIE—
Oct 26, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 24, 2006TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 13, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 13, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 10, 2006GNSIINQUIRY TO SUSPENSION E-MAILED—
Aug 10, 2006CNSISUSPENSION INQUIRY WRITTEN—
Aug 9, 2006RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jan 23, 2006GNSLLETTER OF SUSPENSION E-MAILED—
Jan 23, 2006CNSLSUSPENSION LETTER WRITTEN—
Jan 17, 2006DOCKASSIGNED TO EXAMINER—
Nov 16, 2005TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 7, 2005TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 7, 2005TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 19, 2005NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance